In this annual tradition, Drs Harrington and Gibson discuss their picks for the top cardiology trials of the year, covering PCSK9 inhibitors, anti-inflammatory and anthithrombotic drugs, and PCI.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
